The IQSEC1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human HAP1 cell line, engineered for loss-of-function analysis of IQSEC1. This polyclonal product comprises a heterogeneous pool of cells carrying targeted disruption of the IQSEC1 locus, enabling robust investigation of its cellular roles without clonal selection.
HAP1 is a near-haploid, fibroblast-like human cell line from chronic myeloid leukemia, characterized by a stable haploid karyotype and adherent growth. Its single allele per gene eliminates complications from diploidy, making it an optimal platform for CRISPR-based genetic screening. HAP1 cells maintain active integrin and growth factor signaling, providing a relevant context for studying membrane trafficking and cytoskeletal dynamics.
IQSEC1 acts as a GEF for ARF6, catalyzing its GTP loading. Following integrin engagement or calcium influx, calmodulin binds IQSEC1 and stimulates ARF6 activation. ARF6-GTP triggers actin polymerization, membrane ruffling, and integrin recycling, essential for cell adhesion and motility. Downstream mediators such as Rac1 and PIP5K further relay signals to the cytoskeleton. IQSEC1 additionally associates with phosphoinositides and IQ motif proteins, integrating pathways that control membrane dynamics and cell shape.
In the HAP1 context, disruption of IQSEC1 is expected to blunt ARF6-GTP levels, leading to defects in integrin recycling, reduced cell-substrate adhesion, and impaired migration. The near-haploid nature of HAP1 ensures a clean knockout phenotype without interference from a second allele, making it a rigorous system for dissecting IQSEC1??s contribution to ARF6 signaling and cancer-related cell motility. This model is particularly valuable for studying the mechanistic interplay between membrane trafficking and cytoskeletal reorganization in a simplified genetic background.
These polyclonal knockout cells are well-suited for a range of functional assays. Western blotting can measure active ARF6 and phosphorylation of FAK, while immunofluorescence visualizes actin stress fibers and integrin distribution. Transwell migration and adhesion assays quantify cell motility and substrate attachment. Co-immunoprecipitation enables analysis of the IQSEC1-ARF6 interaction, and flow cytometry assesses surface integrin expression. Research applications include cancer metastasis modeling, neurobiology, and investigation of invasive migration pathologies. For detailed protocols and support, please contact Ascent Research.
